01.29.15
Ravensburg, Germany-based Vetter (Vetter Pharma-Fertigung GmbH & Co. KG), which fills and finishes pre-filled syringes, cartridges and vials, has completed the first phase of its new site in Ravensburg had been completed. Estimated to be fully operational by the beginning of 2016, the new facility will contain high-tech laboratories and workplaces for Vetter Development Service, as well as a secure data center and additional office space for a total area of 8,500 square meters. The 26 million Euro (U.S. $25.9 million) investment is a direct result of increased demand by customers for support in drug development, as well as the need for enhanced company-wide IT systems to meet future requirements the company is seeing today.
Vetter decided to expand its facility in Germany due to increased demand. The six-story building will contain laboratory space for performing microbiological analysis, and will also have sufficient spare capacity to meet future growth needs such as additional cleanrooms and labs.
The multi-functional building is also an investment in future-oriented IT systems which help Vetter meet the increasing quality and security needs of customers and regulatory authorities alike. For example, the new data center will have enhanced security systems and a safety cell that protects technology and data from external physical hazards, as well as a state-of-the-art gas extinguishing system to minimize damage in the event of an emergency.
“With this new building, we are addressing the growing demand of our customers in the area of clinical drug development and manufacturing,” said Thomas Otto, a Vetter Managing Director. “Furthermore, with the installation of the sophisticated IT systems, Vetter will be well-prepared to meet future challenges that present themselves.”
Vetter decided to expand its facility in Germany due to increased demand. The six-story building will contain laboratory space for performing microbiological analysis, and will also have sufficient spare capacity to meet future growth needs such as additional cleanrooms and labs.
The multi-functional building is also an investment in future-oriented IT systems which help Vetter meet the increasing quality and security needs of customers and regulatory authorities alike. For example, the new data center will have enhanced security systems and a safety cell that protects technology and data from external physical hazards, as well as a state-of-the-art gas extinguishing system to minimize damage in the event of an emergency.
“With this new building, we are addressing the growing demand of our customers in the area of clinical drug development and manufacturing,” said Thomas Otto, a Vetter Managing Director. “Furthermore, with the installation of the sophisticated IT systems, Vetter will be well-prepared to meet future challenges that present themselves.”